Literature DB >> 11758752

Additional transporter characterization may lead to new pharmaceutical opportunities.

O S Gudmundsson1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11758752     DOI： 10.1023/a:1013014709104

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  10 in total

1.  Inhibition of P-glycoprotein transport function by grapefruit juice psoralen.

Authors:  E J Wang; C N Casciano; R P Clement; W W Johnson
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

2.  HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein.

Authors:  E Wang; C N Casciano; R P Clement; W W Johnson
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

Review 3.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Authors:  S V Ambudkar; S Dey; C A Hrycyna; M Ramachandra; I Pastan; M M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

4.  Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.

Authors:  A B Shapiro; V Ling
Journal:  Eur J Biochem       Date:  1997-11-15

5.  Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice.

Authors:  S Cisternino; C Rousselle; C Dagenais; J M Scherrmann
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

6.  A functional assay for quantitation of the apparent affinities of ligands of P-glycoprotein in Caco-2 cells.

Authors:  J Gao; O Murase; R L Schowen; J Aubé; R T Borchardt
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

7.  Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site.

Authors:  A B Shapiro; K Fox; P Lam; V Ling
Journal:  Eur J Biochem       Date:  1999-02

8.  Physicochemical parameters responsible for the affinity of methotrexate analogs for rat canalicular multispecific organic anion transporter (cMOAT/MRP2).

Authors:  Y H Han; Y Kato; M Haramura; M Ohta; H Matsuoka; Y Sugiyama
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

9.  P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier.

Authors:  I C van der Sandt; P J Gaillard; H H Voorwinden; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

10.  Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein.

Authors:  S Dey; M Ramachandra; I Pastan; M M Gottesman; S V Ambudkar
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.